Article Details

Encorafenib Plus Binimetinib Improves Long-Term PFS, OS in BRAF V600-Mutant Melanoma

Retrieved on: 2022-08-01 20:44:47

Tags for this article:

Click the tags to see associated articles and topics

Encorafenib Plus Binimetinib Improves Long-Term PFS, OS in BRAF V600-Mutant Melanoma. View article details on hiswai: https://www.cancertherapyadvisor.com/home/news/melanoma-encorafenib-binimetinib-improves-pfs-os-braf-v600-mutant/

Excerpt

The trial was not powered for OS comparisons between the treatment arms. However, the median OS was significantly longer in the combination arm than ...

Article found on: www.cancertherapyadvisor.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up